Åsa Wallin

41 – 50 of 56

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/person/fd009874-384a-4927-a462-9067b6c9f957?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

2009
Mark Changes in cognitive domains during three years in patients with Alzheimer's disease treated with donepezil
Persson, Cecilia ^LU ; Wallin, Åsa ^LU ; Levander, Sten ^LU and Minthon, Lennart ^LU (2009) In BMC Neurology 9.
- Contribution to journal › Article
Mark Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study
Visser, Pieter Jelle ; Verhey, Frans ; Knol, Dirk L. ; Scheltens, Philip ; Wahlund, Lars-Olof ; Freund-Levi, Yvonne ; Tsolaki, Magda ; Minthon, Lennart ^LU ; Wallin, Åsa ^LU and Hampel, Harald , et al. (2009) In Lancet Neurology 8(7). p.619-627
- Contribution to journal › Article
Mark Risk Factors for Nursing Home Placement in Cholinesterase Inhibitor Treated Naturalistic Alzheimer Patients.
Wattmo, Carina ^LU ; Wallin, Åsa ^LU and Minthon, Lennart ^LU (2009) 9th International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD)
- Contribution to conference › Poster
2008
Mark Predicting Long-Term Cognitive Outcome with New Regression Models in Donepezil-Treated Alzheimer Patients in a Naturalistic Setting.
Wattmo, Carina ^LU ; Hansson, Oskar ^LU ; Wallin, Åsa ^LU ; Londos, Elisabet ^LU and Minthon, Lennart ^LU (2008) In Dementia and Geriatric Cognitive Disorders 26(3). p.203-211
- Contribution to journal › Article
Mark Long-term treatment response, predictors and biochemical markers in Alzheimer’s disease.
Wallin, Åsa ^LU (2008) In Lund University Faculty of Medicine Doctoral Dissertation Series 2008:73.
- Thesis › Doctoral thesis (compilation)
2007
Mark Donepezil in Alzheimer's disease: what to expect after 3 years of treatment in a routine clinical setting.
Wallin, Åsa ^LU ; Andreasen, Niels ; Eriksson, Sture ; Båtsman, Stellan ; Näsman, Birgitta ; Ekdahl, Anne ; Kilander, Lena ; Grut, Mikaela ; Rydén, Marie and Wallin, Anders , et al. (2007) In Dementia and Geriatric Cognitive Disorders 23(3). p.150-160
- Contribution to journal › Article
Mark Alzheimer's disease - Safety and dropout in long-term galantamine treatment in a routine clinical setting
Wallin, Åsa ^LU ; Wattmo, Carina ^LU and Minthon, Lennart ^LU (2007) 8th International Conference on Alzheimers and Parkinsons Diseases p.245-249
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
Mark Activities of daily living - Outcome during two years in galantamine treated Alzheimer patients
Wattmo, Carina ^LU ; Wallin, Åsa ^LU and Minthon, Lennart ^LU (2007) 8th International Conference on Alzheimer`s and Parkinson`s Diseases (AD/PD 2007) p.251-255
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
Mark Three-year outcome of Galantamine treatment in Alzheimer’s disease in a routine clinical setting.
Wallin, Åsa ^LU ; Wattmo, Carina ^LU and Minthon, Lennart ^LU (2007) IPA (International Psychogeriatric Association) 2007 Osaka Silver Congress
- Contribution to conference › Poster
Mark Activities of Daily Living – Outcome During Three Years in Donepezil Treated Alzheimer Patients.
Wattmo, Carina ^LU ; Wallin, Åsa ^LU and Minthon, Lennart ^LU (2007) IPA (International Psychogeriatric Association) 2007 Osaka Silver Congress
- Contribution to conference › Poster